Tesidolumab Biosimilar - Anti-C5 mAb - Research Grade
Source
CAS 1531594-08-7
Species
Homo sapiens
Expression system
Mammalian cells
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Tesidolumab,LFG 316, LFG-316, LFG316,C5,anti-C5
Reference
PX-TA1373
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-lambda
Clonality
Monoclonal Antibody
Description of Tesidolumab Biosimilar - Anti-C5 mAb - Research Grade
General information on Anti-C5[Homo sapiens] (Tesidolumab) Monoclonal Antibody
Tesidolumab has been investigated for the treatment of Geographic Atrophy, Non-infectious Panuveitis, Exudative Macular Degeneration, Non-infectious Posterior Uveitis, and Age-related Macular Degeneration
Tesidolumab Biosimilar - Anti-C5 mAb binds to Human C5 in indirect ELISA Assay
Immobilized Human C5 recombinant protein (cat. No. PX-P5117) at 0.5µg/mL (100µL/well) can bind Tesidolumab Biosimilar - Anti-C5 mAb (cat. No. PX-TA1373) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 21.50M.
Tesidolumab Biosimilar - Anti-C5 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Tesidolumab Biosimilar – Anti-C5 mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.